Healthcare

Smart Syringes Market Estimated to Generate a Revenue of US$ 15.46 By 2030 | Potential Opportunity Is Opening Up In The Coming Year (2021-2030)

The global smart syringes market size is forecasted to reach from US$ 7.84 billion in 2021 to US$ 15.46 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 7.8% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.

The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The smart syringes market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decision to sustain growth through the assessment period.

Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1438

The smart syringes perfectly serves the need for safe injection practices by eliminating the re-use of syringes. Moreover, the growing demand for the minimally invasive procedures among the population is boosting the demand for the smart syringes. The smart syringes prevents the injuries that are associated with the needle sticks of the traditional injections. It also eliminates the spread of certain blood-borne diseases such as HIV, hepatitis B, and hepatitis C. Furthermore, the rising applications of the smart syringes for various applications like vaccination, collection of blood specimen, and drug delivery is augmenting the demand for the smart syringes across the globe. The recommendations of the World Health Organization to adopt the use of the smart syringes in order to avoid needle stick injuries and promote good injection practices all over the globe is spurring the growth of the global smart syringes market.

Scope of the Smart Syringes Market

Report Coverage Details
Market Size In 2021 USD 15.46 Billion
Growth Rate From 2021 to 2030 CAGR of 7.8%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
By Application
  • Vaccination
  • Drug Delivery
  • Blood Specimen Collection

Competitive Landscape Analysis:

Some of the leading companies operating in the smart syringes market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Major companies operating in this report are

  • Becton, Dickinson and Company
  • Gerresheimer AG
  • Baxter
  • Terumo Corporation
  • B. Braun Melsungen AG
  • AdvaCare Pharma
  • Cardinal Health
  • Parker Hannifin Corp.
  • Numedico Technologies Pty Ltd
  • Retractable Technologies, Inc.

COVID-19 Impact

The COVID-19 pandemic had been expected to accelerate the demand for smart syringes, because of the rise in the covid vaccination process. Countries, worldwide, have been spending a significant sum of capital to purchase vaccines and medical equipment, to vaccinate their population.

Major companies have been making a significant impact in the market. For instance, in June 2021, IHDLife, one of the key players in the market, announced that it had been shipping two million auto-disable syringes to the United States government, intending to ensure vaccination against the covid virus.

There are other developments in the market. For instance, in November 2020, Hindustan Syringes & Medical Devices Ltd., announced that it had shipped over 100+ million pieces of KOJAK auto-disable syringes to COVAX, the global vaccination organization’s stockpile facility. The company had also stated that they had been planning to allocate more than 50% of the total 0.5 ML auto-disable syringes for export and the rest 50% for the government of India.

In February 2021, UNICEF announced that it had sent 100,000+ syringes to the Maldives for COVID-19 vaccination. The organization had also stated that they would ship over 14.5 million auto-disable syringes to more than 30 nations, globally. been These trends are expected to have a positive impact on the market, in the coming period.

Market Dynamics

Drivers

  • Increasing Number of Various Target Diseases
  • Growth in Awareness of Smart Syringes
  • Surge in Incidences of Needlestick Injuries
  • Rapid Technological Advancements

Restraints

  • High Cost and Unaffordability of Safety Syringes
  • Alternative Modes of Drug Delivery

Opportunities

  • Rise in Need for Auto Disposable Syringes
  • Growth of the Geriatric Population

Challenges

  • Soaring Costs of Vaccines

Segments Covered in the Report

By Product

  • Auto Disable Syringes
  • Passive Safety Syringes
  • Active Safety Syringes

By Application

  • Vaccination
  • Drug Delivery
  • Blood Specimen Collection

By End User

  • Hospitals
  • Psychiatrics
  • Family Practices
  • Diabetic Patients
  • Others

Regional Segmentation

– North America (U.S. and Canada)

 – Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)

 – Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)

 – Latin America (Brazil and Rest of Latin America)

– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Why should you invest in this report?

If you are aiming to enter the global smart syringes market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for smart syringes are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1438

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Smart Syringes Market 

5.1. COVID-19 Landscape: Smart Syringes Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Smart Syringes Market, By Product

8.1. Smart Syringes Market, by Product Type, 2021-2030

8.1.1. Auto Disable Syringes

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Passive Safety Syringes

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Active Safety Syringes

8.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Smart Syringes Market, By Application

9.1. Smart Syringes Market, by Application, 2021-2030

9.1.1. Vaccination

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Drug Delivery

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Blood Specimen Collection

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Smart Syringes Market, By End User 

10.1. Smart Syringes Market, by End User, 2021-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Psychiatrics

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Family Practices

10.1.3.1. Market Revenue and Forecast (2019-2030)

10.1.4. Diabetic Patients

10.1.4.1. Market Revenue and Forecast (2019-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Smart Syringes Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)

Chapter 12. Company Profiles

12.1. Becton, Dickinson and Company

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Gerresheimer AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Baxter

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Terumo Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. B. Braun Melsungen AG

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. AdvaCare Pharma

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cardinal Health

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Parker Hannifin Corp.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Numedico Technologies Pty Ltd

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Retractable Technologies, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1438

Contact Us:         

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button